Journal article · 2026

Discovery, Synthesis, and Biological Evaluation of 1,3,4,5-Tetrahydro-6 H -pyrano[4,3- c ]isoquinolin-6-one Derivatives as Novel and Highly Selective PARP1 Inhibitors

Zhongning Guo, Rongrong Sun, Linyu Yang, Yurong Zou, Tao Guo, Ziyan Ma, Shuai Liu, Peng Wang, Yongting Yuan, Lingping Ye, Yonglin Chen, Songhui Qin and 8 more

Journal of Medicinal Chemistry, 69(15), 18051–18075 · Published 4 August 2026 · DOI 10.1021/acs.jmedchem.6c00295

View at the publisherCite this paper

In brief

“Discovery, Synthesis, and Biological Evaluation of 1,3,4,5-Tetrahydro-6 H -pyrano[4,3- c ]isoquinolin-6-one Derivatives as Novel and Highly Selective PARP1 Inhibitors” is a 2026 journal article by Zhongning Guo and 19 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 1 citations as of 19 November 2026, which puts it in the top 9% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
2.40
References
32
Authors
20

Abstract

Developing highly selective PARP1 inhibitors is a promising strategy to improve the therapeutic window compared with dual PARP1/2 inhibitors. Through structure-guided design and optimization, we developed (R)-A17, a novel, highly selective PARP1 inhibitor featuring a unique tricyclic scaffold. It demonstrates nanomolar enzymatic potency (PARP1 IC50 = 2.4 nM), exceptional 65.8-fold selectivity over PARP2, and robust… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Guo, Z., Sun, R., Yang, L., Zou, Y., Guo, T., Ma, Z., Liu, S., Wang, P., Yuan, Y., Ye, L., Chen, Y., Qin, S., Li, N., Bai, P., Yuan, Q., Yan, W., Bo, W., Wang, T., Hu, J., & Chen, L. (2026). Discovery, Synthesis, and Biological Evaluation of 1,3,4,5-Tetrahydro-6 H -pyrano[4,3- c ]isoquinolin-6-one Derivatives as Novel and Highly Selective PARP1 Inhibitors. Journal of Medicinal Chemistry, 69(15), 18051–18075. https://doi.org/10.1021/acs.jmedchem.6c00295

MLA 9

Guo, Zhongning, et al. “Discovery, Synthesis, and Biological Evaluation of 1,3,4,5-Tetrahydro-6 H -pyrano[4,3- c ]isoquinolin-6-one Derivatives as Novel and Highly Selective PARP1 Inhibitors.” Journal of Medicinal Chemistry, vol. 69, no. 15, 2026, pp. 18051–18075. https://doi.org/10.1021/acs.jmedchem.6c00295.

Chicago

Guo, Zhongning, Rongrong Sun, Linyu Yang, Yurong Zou, Tao Guo, Ziyan Ma, Shuai Liu, et al. 2026. “Discovery, Synthesis, and Biological Evaluation of 1,3,4,5-Tetrahydro-6 H -pyrano[4,3- c ]isoquinolin-6-one Derivatives as Novel and Highly Selective PARP1 Inhibitors.” Journal of Medicinal Chemistry 69 (15): 18051–18075. https://doi.org/10.1021/acs.jmedchem.6c00295.

Harvard

Guo, Z. et al. (2026) ‘Discovery, Synthesis, and Biological Evaluation of 1,3,4,5-Tetrahydro-6 H -pyrano[4,3- c ]isoquinolin-6-one Derivatives as Novel and Highly Selective PARP1 Inhibitors’, Journal of Medicinal Chemistry, 69(15), pp. 18051–18075. doi:10.1021/acs.jmedchem.6c00295.

IEEE

Z. Guo et al., “Discovery, Synthesis, and Biological Evaluation of 1,3,4,5-Tetrahydro-6 H -pyrano[4,3- c ]isoquinolin-6-one Derivatives as Novel and Highly Selective PARP1 Inhibitors,” Journal of Medicinal Chemistry, vol. 69, no. 15, pp. 18051–18075, 2026, doi: 10.1021/acs.jmedchem.6c00295.

BibTeX

@article{guo2026discovery,
  title     = {{Discovery, Synthesis, and Biological Evaluation of 1,3,4,5-Tetrahydro-6 H -pyrano[4,3- c ]isoquinolin-6-one Derivatives as Novel and Highly Selective PARP1 Inhibitors}},
  author    = {Guo, Zhongning and Sun, Rongrong and Yang, Linyu and Zou, Yurong and Guo, Tao and Ma, Ziyan and Liu, Shuai and Wang, Peng and Yuan, Yongting and Ye, Lingping and Chen, Yonglin and Qin, Songhui and Li, Na and Bai, Peng and Yuan, Quan and Yan, Wei and Bo, Weichen and Wang, Taijin and Hu, Jiankun and Chen, Lijuan},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2026},
  volume    = {69},
  number    = {15},
  pages     = {18051--18075},
  doi       = {10.1021/acs.jmedchem.6c00295},
  url       = {https://doi.org/10.1021/acs.jmedchem.6c00295}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy

  • PARP-1 inhibitors
  • poly(ADP-ribosyl)ation
  • G2/M cell cycle arrest
  • DNA damage
  • oral bioavailability
  • anticancer activity
  • structure-based drug design

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Guo, Z., Sun, R., Yang, L., Zou, Y., Guo, T., Ma, Z., Liu, S., Wang, P., Yuan, Y., Ye, L., Chen, Y., Qin, S., Li, N., Bai, P., Yuan, Q., Yan, W., Bo, W., Wang, T., Hu, J., & Chen, L. (2026). Discovery, Synthesis, and Biological Evaluation of 1,3,4,5-Tetrahydro-6 H -pyrano[4,3- c ]isoquinolin-6-one Derivatives as Novel and Highly Selective PARP1 Inhibitors. Journal of Medicinal Chemistry, 69(15), 18051–18075. https://doi.org/10.1021/acs.jmedchem.6c00295

How many times has this paper been cited?

1 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Zhongning Guo, Rongrong Sun, Linyu Yang, Yurong Zou, Tao Guo, Ziyan Ma, Shuai Liu, Peng Wang, Yongting Yuan, Lingping Ye, Yonglin Chen, Songhui Qin and 8 more.

What is the DOI of this paper?

10.1021/acs.jmedchem.6c00295, permanently at https://doi.org/10.1021/acs.jmedchem.6c00295. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.